Tespa1 deficiency reduces the antitumour immune response by decreasing CD8<sup>+</sup>T cell activity in a mouse Lewis lung cancer model.

Tespa1 deficiency reduces the antitumour immune response by decreasing CD8⁺T cell activity in a mouse Lewis lung cancer model.

Yang, Ruhui; Yang, Mingyue; Wu, Zehua; Liu, Bingjin; Zheng, Mingzhu; Lu, Linrong; Wu, Songquan.

Afiliação

Yang R; School of Medicine and Pharmaceutical Engineering, Taizhou Vocational and Technical College, Taizhou 318000, China; Department of Pharmacology, Lishui University School of Medicine, Lishui 323000, China.
Yang M; The First Clinical Department, China Medical University, Shenyang 110122, China.
Wu Z; Faculty of Science and Engineering, University of Nottingham, Ningbo, 315000, China.
Liu B; School of Medicine and Pharmaceutical Engineering, Taizhou Vocational and Technical College, Taizhou, 318000, China.
Zheng M; Department of Pathogenic Biology and Immunology, School of Medicine, Southeast University, Nanjing, 210003, China.
Lu L; Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
Wu S; Department of Immunology, Lishui University School of Medicine, Lishui 323000, China. Electronic address: zjlswsq@163.com.

Int Immunopharmacol ; 124(Pt A): 110865, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37660596